Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 3:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1897–1920 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Hypertension, Obesity
Interventions: Neuropeptide Y; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 55 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Lung Disease, Pulmonary Hypertension
Interventions: Observational Study; Diagnostic Test
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 100 participants
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy, Glaucoma
Interventions: Not listed
Lead sponsor: Optovue; Industry
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Daly City, California

Conditions: Hypotension, Hypertension
Interventions: Non-invasive non-oscillometric blood pressure wristband device, Invasive intra-arterial blood pressure monitors.; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 100 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: High Cholesterol, High Blood Pressure, Colorectal Cancer, Breast Cancer, Prostate Cancer
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 30 Years to 75 Years
Enrollment: 539 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Lymphocytic Leukemia, Atrial Fibrillation, Hypertension, Cardiotoxicity
Interventions: no intervention; Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 22 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hernia, Diaphragmatic, Hypertension, Pulmonary, Hypoplasia, Pulmonary
Interventions: sildenafil, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 10 Days to 42 Days
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 3
States / cities: Los Angeles, California • San Francisco, California • Chicago, Illinois

Conditions: Hypertension, Diabetes
Interventions: Salsalate, Carvedilol, Placebo, Intralipid 20%; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cirrhosis, Liver, Sarcopenia
Interventions: Transjugular Intrahepatic Portosystemic Shunt (TIPS) creation; Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Glaucoma
Interventions: Tonometer; Device
Lead sponsor: Topcon Corporation; Industry
Eligibility: 22 Years and older
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 2
States / cities: La Mesa, California • Chicago, Illinois

Conditions: Chronic Kidney Diseases, Hypertension, Diabetes
Interventions: CKD enhanced clinical decision support; Other
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 6,295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Bloomington, Minnesota

Conditions: Right Heart Failure, Pulmonary Hypertension
Interventions: Spironolactone and conivaptan; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Pre-Eclampsia
Interventions: Echocardiogrpahy and non-invasive monitoring; Diagnostic Test
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Open Angle Glaucoma
Interventions: Not listed
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obesity, Hypertension, Depression
Interventions: 6 week challenge with 1 year of home visits: health texting, in home exercise supports, social support, healthy eating and feeding classes; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: Female only
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertension
Interventions: PRM-125; Drug
Lead sponsor: PRM Pharma, LLC; Industry
Eligibility: 30 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Preeclampsia
Interventions: Not listed
Lead sponsor: Medical University of South Carolina; Other
Eligibility: Female only
Enrollment: 316 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Natriuretic Peptides, Cardiovascular Diseases, Hypertension, Diabetes, Obesity
Interventions: Not listed
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Glaucoma
Interventions: Tono-Vera tonometer, Goldman Applanation Tonometry; Device
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Respiratory Distress Syndrome (RDS), Sepsis, Pneumonia, Hypertension, Pulmonary
Interventions: Inhaled nitric oxide, Placebo; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 120 Hours
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 14 more

Conditions: Hypertension
Interventions: Not listed
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Hypertension
Interventions: Aliskiren, Hydrochlorothiazide; Drug
Lead sponsor: Novartis; Industry
Eligibility: 55 Years and older
Enrollment: 451 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Hypertension
Interventions: Placebo, ISIS 757456; Drug
Lead sponsor: Ionis Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 9
States / cities: Birmingham, Alabama • Los Angeles, California • Tustin, California + 6 more

Search by objective public record fields.

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension

Clinical Validation Study of RTVue Features

Accuracy of Non-invasive Non-oscillometric Blood Pressure Wristband

Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey

Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors

Chronic Sildenafil for Severe Diaphragmatic Hernia

Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)

Body Composition Changes After TIPS and Associated Clinical Outcomes

TRK-3 Conformance to Standards for Tonometers

Chronic Kidney Disease Clinical Decision Support

Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

Determinants of Compliance With Glaucoma Therapy

Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension

Postpartum Weight Retention

Effect of PRM-125 on Ambulatory Blood Pressure

Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia

CARBON: UAB Cardiovascular Research Biobank

Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Emergency Department Home Blood Pressure Monitoring and BpTRU Study

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx